Ionis Pharmaceuticals, Inc. Common Stock (IONS) is a publicly traded Healthcare sector company. As of August 25, 2026, IONS trades at $63.76 with a market cap of $9.93B and a P/E ratio of -130.56. IONS moved +2.78% today. Year to date, IONS is -21.58%; over the trailing twelve months it is +45.33%. Its 52-week range spans $23.95 to $86.74. Analyst consensus is strong buy with an average price target of $88.67. Rallies surfaces IONS's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
IONS financials on Rallies include revenue, net income, EPS, valuation metrics, market cap, price history, and balance sheet context. IONS recently traded at $63.76. Market cap is $9.93B. P/E ratio is -130.56. Revenue is $874.09M.
| Metric | Value |
|---|---|
| Price | $63.76 |
| Market Cap | $9.93B |
| P/E Ratio | -130.56 |
| EPS | $-0.47 |
| Dividend Yield | 0.00% |
| 52-Week High | $86.74 |
| 52-Week Low | $23.95 |
| Volume | 1.24M |
| Avg Volume | 0 |
| Revenue (TTM) | $874.09M |
| Net Income | $-565.17M |
| Gross Margin | 98.17% |
20 analysts cover IONS: 0 strong buy, 16 buy, 4 hold, 0 sell, 0 strong sell. Consensus rating is strong buy. Average price target: $88.67.